IPO Update

Corona Remedies’ initial public offering has attracted overwhelming investor interest, closing with a subscription level of 9.33 times. The strong response reflects heightened confidence in the company’s fundamentals, product portfolio, and long-term growth potential in India’s expanding pharmaceutical market. Driven by participation from institutional investors, non-institutional bidders, and retail applicants, the IPO gained momentum throughout the bidding period.

AceVector, a rising player in the technology and service sector, has announced its initial public offering (IPO), aiming to raise Rs 300 crore through a fresh issue of shares. The move seeks to bolster the company’s growth capital, fund expansion initiatives, and strengthen its balance sheet. Market analysts suggest that the IPO reflects investor confidence in AceVector’s business model and growth trajectory. The offering is expected to attract institutional and retail participation, as the company positions itself for strategic scaling.

Meesho’s initial public offering closed with extraordinary enthusiasm, recording an impressive 79 times subscription on the final day. The robust response reflects strong investor confidence in India’s rapidly expanding e-commerce landscape and Meesho’s unique position as a marketplace serving small sellers, regional brands, and value-conscious consumers. Heavy demand across institutional, non-institutional, and retail categories underscores the company’s growth potential, strengthened financials, and digital-first business model.

The ₹300-crore public offering by Vidya Wires has drawn overwhelming investor enthusiasm, ending its subscription period with bids amounting to nearly 26.6 times the shares on offer. The strong response underscores robust market appetite for the company’s electrical-wiring product portfolio and expansion plans. Despite a modest recent track record, the firm’s growth outlook—boosted by capacity addition and exposure to sectors like EVs, power transmission and clean energy—has captured investor imagination.

Park Medi is preparing to enter the capital markets with an initial public offering scheduled to open on December 10, marking a significant milestone for the healthcare services provider. The IPO will offer investors an opportunity to participate in the company’s expansion strategy, backed by rising demand for specialized medical solutions across India. With a defined price band and structured offering, Park Medi aims to leverage public market participation to strengthen its infrastructure, diversify service lines, and scale operations.

Gaja Capital has taken a significant step toward its public listing by submitting updated draft papers for an initial public offering valued at Rs. 656 crore. The revised filing reflects the fund’s intentions to strengthen its capital base, enhance market visibility, and prepare for long-term expansion within India’s evolving private equity landscape. The updated draft also signals improved clarity on issue structure, regulatory compliance, and fundraising objectives.

The specialty-chemicals manufacturer Neochem Bio Solutions is launching its Initial Public Offering (IPO) between December 2 and December 4, 2025, aiming to raise approximately ₹44.97 crore through a fresh issue. Priced at ₹93–₹98 per share, the issue comprises 45.88 lakh equity shares and is scheduled for listing on the NSE Emerge platform on December 9. Anchor investors have already committed around ₹12.77 crore. The company intends to deploy the proceeds toward working-capital needs, debt repayment, and general corporate purposes.

The Sanjay Ghodawat Group (SGG), a diversified Indian conglomerate with interests spanning consumer products, renewable energy, aviation, and real estate, is charting an ambitious growth trajectory as it eyes Rs 15,000 crore in revenue over the coming years. Alongside this expansion plan, the group is also preparing for a potential initial public offering, signalling its intent to strengthen governance, enhance capital access, and accelerate scale across key business verticals.

Wakefit, a leading home-and-sleep solutions brand, is preparing to launch its initial public offering on December 8, featuring a fresh issue of Rs 377 crore. The company, known for its rapid expansion in the online furniture and sleep-products market, aims to strengthen its balance sheet, enhance manufacturing capabilities, and scale distribution through the proceeds. Investors are closely watching the issue, given Wakefit’s strong digital-first strategy, robust revenue traction, and growing footprint in India’s home lifestyle sector.

India’s primary market is entering one of its most active phases in recent years, with companies collectively preparing to raise more than Rs. 40,000 crore through initial public offerings. The surge reflects strong investor appetite, resilient domestic liquidity, and corporate confidence in equity valuations. As diverse sectors—from manufacturing to financial services—rush to tap the markets, regulators and exchanges are seeing a sharp acceleration in draft prospectus filings and listing preparations.